open access

Online first
Original article
Published online: 2022-12-27
Get Citation

Headache after transcatheter closure of atrial septal defect: An attempt to explain its origin in pediatric population

Sebastian Smerdziński12, Michał Gałeczka1, Filip Tyc12, Mateusz Knop12, Jacek Białkowski12, Roland Fiszer12
DOI: 10.33963/KP.a2023.0001
·
Pubmed: 36594530
Affiliations
  1. Department of Congenital Heart Defects and Pediatric Cardiology, Silesian Center for Heart Diseases, Zabrze, Poland
  2. Faculty of Medical Sciences in Zabrze, Medical University of Silesia, Katowice, Poland

open access

Online first
Original article
Published online: 2022-12-27

Abstract

BACKGROUND: Transcatheter closure of atrial septal defect (ASD) has become the treatment of choice for most patients. About 5% of them after the procedure suffer from the transient headache episodes (THE), the etiology of which is unclear.

AIMS: To evaluate risk factors for THE occurrence after transcatheter closure of ASD in the pediatric population.

METHODS: 840 patients, after transcatheter ASD closure, with nitinol devices, from a single center, were included in retrospective analysis. THE was defined as occurring up to 24 hours after procedure. A logistic regression model including age, weight, ASD diameter, device size, presence of nitinol coating on device, fluoroscopy time, application of balloon calibration, device oversizing and residual shunt after 24 hours was created to evaluate risk factors for THE occurrence.

RESULTS: There were 40 patients (females 70%) with THE (4.8%). Median age was 13 (7.35–16) years. 40 patients (4.8%) with THE. Female 70%, male 30%. Median age 13 (7.35–16) years. Among patients with headache BC was performed more frequently (82.5% vs. 43.3%; P <0.001), the balloon waist median (interquartile range [IQR]), 19 (16–22) mm vs. 15 mm (12–18) mm; P P P  = 0.03) and a year (7.5 vs. 1.0%; P <0.001) was more frequent. ASD size and prevalence of double/multiple ASD were similar in both groups. Age, application of BC, no nickel release protection, duration of fluoroscopy and device oversizing were predictors of THE (P <0.001).

CONCLUSIONS: Balloon calibration during percutaneous ASD closure and absent nickel release protection layer on the device are risk factors of headache occurrence in the early postprocedural period.

Abstract

BACKGROUND: Transcatheter closure of atrial septal defect (ASD) has become the treatment of choice for most patients. About 5% of them after the procedure suffer from the transient headache episodes (THE), the etiology of which is unclear.

AIMS: To evaluate risk factors for THE occurrence after transcatheter closure of ASD in the pediatric population.

METHODS: 840 patients, after transcatheter ASD closure, with nitinol devices, from a single center, were included in retrospective analysis. THE was defined as occurring up to 24 hours after procedure. A logistic regression model including age, weight, ASD diameter, device size, presence of nitinol coating on device, fluoroscopy time, application of balloon calibration, device oversizing and residual shunt after 24 hours was created to evaluate risk factors for THE occurrence.

RESULTS: There were 40 patients (females 70%) with THE (4.8%). Median age was 13 (7.35–16) years. 40 patients (4.8%) with THE. Female 70%, male 30%. Median age 13 (7.35–16) years. Among patients with headache BC was performed more frequently (82.5% vs. 43.3%; P <0.001), the balloon waist median (interquartile range [IQR]), 19 (16–22) mm vs. 15 mm (12–18) mm; P P P  = 0.03) and a year (7.5 vs. 1.0%; P <0.001) was more frequent. ASD size and prevalence of double/multiple ASD were similar in both groups. Age, application of BC, no nickel release protection, duration of fluoroscopy and device oversizing were predictors of THE (P <0.001).

CONCLUSIONS: Balloon calibration during percutaneous ASD closure and absent nickel release protection layer on the device are risk factors of headache occurrence in the early postprocedural period.

Get Citation

Keywords

balloon calibration, headache

About this article
Title

Headache after transcatheter closure of atrial septal defect: An attempt to explain its origin in pediatric population

Journal

Kardiologia Polska (Polish Heart Journal)

Issue

Online first

Article type

Original article

Published online

2022-12-27

Page views

82

Article views/downloads

49

DOI

10.33963/KP.a2023.0001

Pubmed

36594530

Keywords

balloon calibration
headache

Authors

Sebastian Smerdziński
Michał Gałeczka
Filip Tyc
Mateusz Knop
Jacek Białkowski
Roland Fiszer

References (20)
  1. King TD, Thompson SL, Steiner C, et al. Secundum atrial septal defect. Nonoperative closure during cardiac catheterization. JAMA. 1976; 235(23): 2506–2509.
  2. Guidelines for the Management of Congenital Heart Diseases in Childhood and Adolescence. Cardiol Young. 2017; 27(S3): S1–S105.
  3. Grygier M, Sabiniewicz R, Smolka G, et al. Percutaneous closure of atrial septal defect: a consensus document of the joint group of experts from the Association of Cardiovascular Interventions and the Grown-Up Congenital Heart Disease Section of the Polish Cardiac Society. Kardiol Pol. 2020; 78(10): 1066–1083.
  4. Kubicka K, Kawalec W. Pediatric Cardiology [in Polish]. Warszawa 2003.
  5. Knop MT, Białkowski J, Szkutnik M, et al. Transcatheter closure of atrial septal defects type 2 in children under three years of age. Kardiol Pol. 2018; 76(8): 1257–1262.
  6. Walsh KP, Maadi IM. The Amplatzer septal occluder. Cardiol Young. 2000; 10(5): 493–501.
  7. Masura J, Gavora P, Formanek A, et al. Transcatheter closure of secundum atrial septal defects using the new self-centering amplatzer septal occluder: initial human experience. Cathet Cardiovasc Diagn. 1997; 42(4): 388–393, doi: 10.1002/(sici)1097-0304(199712)42:4<388::aid-ccd7>3.0.co;2-7.
  8. The Amplatzer septal occluder and delivery system instruction for use. Available online: www.accessdata.fda.gov/cdrh_docs/pdf/P000039c.pdf. [Access: December 27, 2022].
  9. Bergersen L, Foerster S, Marshall AC, et al. Congenital heart disease. Springer 2009.
  10. Du ZD, Cao QL, Rhodes J, et al. Choice of device size and results of transcatheter closure of atrial septal defect using the amplatzer septal occluder. J Interv Cardiol. 2002; 15(4): 287–292.
  11. Amin Z, Hijazi ZM, Bass JL, et al. Erosion of Amplatzer septal occluder device after closure of secundum atrial septal defects: review of registry of complications and recommendations to minimize future risk. Catheter Cardiovasc Interv. 2004; 63(4): 496–502.
  12. Rodés-Cabau J, Mineau S, Marrero A, et al. Incidence, timing, and predictive factors of new-onset migraine headache attack after transcatheter closure of atrial septal defect or patent foramen ovale. Am J Cardiol. 2008; 101(5): 688–692.
  13. Fernandes-Mayorales MD, Fernandez-Jean A, Munoz-Jareno N. Migraine symptoms related to the percutaneous closure of an ostium secundum atrial septal defect: report of four pediatric cases and review of the literature. Cephalalgia. 2007(27): 550–556.
  14. Białkowski J, Szkutnik M. The use of Amplatzer devices in the percutaneous treatment of congenital heart defects in children and adults based on own experience. Kardiol Pol. 2021; 79(10): 1130–1132.
  15. Feltes TF, Bacha E, Beekman RH, et al. Indications for cardiac catheterization and intervention in pediatric cardiac disease: a scientific statement from the American Heart Association. Circulation. 2011; 123(22): 2607–2652.
  16. Ries MW, Kampmann C, Rupprecht HJ, et al. Nickel release after implantation of the Amplatzer occluder. Am Heart J. 2003; 145(4): 737–741.
  17. Wallace S, Dohlen G, Holmstrom H, et al. Cerebral microemboli detection and differentiation during transcatheter closure of atrial septal defect in a pediatric population. Cardiol Young. 2014; 25(1): 1–8.
  18. Carlson KM, Justino H, O'Brien RE, et al. Transcatheter atrial septal defect closure: modified balloon sizing technique to avoid overstretching the defect and oversizing the Amplatzer septal occluder. Catheter Cardiovasc Interv. 2005; 66(3): 390–396.
  19. Wilmshurst PT, Nightingale S, Walsh KP, et al. Clopidogrel reduces migraine with aura after transcatheter closure of persistent foramen ovale and atrial septal defects. Heart. 2005; 91(9): 1173–1175.
  20. Hascoet S, Hadeed K, Marchal P, et al. The relation between atrial septal defect shape, diameter, and area using three-dimensional transoesophageal echocardiography and balloon sizing during percutaneous closure in children. Eur Heart J Cardiovasc Imaging. 2015; 16(7): 747–755.

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By VM Media Group sp. z o.o., ul. Świętokrzyska 73 , 80–180 Gdańsk, Poland

phone:+48 58 320 94 94, fax:+48 58 320 94 60, e-mail: viamedica@viamedica.pl